Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) and Tarveda Therapeutics, Inc. today annonced an exclusive worldwide license agreement providing for the discovery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE